Reference Citation Analysis: Find an Article, Find a Category, Find a Journal, Find a Scholar

Download

Total Articles

1
(from Reference Citation Analysis)

Article PDFs (1)

Cited by > 0 (0)

Searched Name

treatment course length

Ranked By

Results Analysis

Results Analysis

Indexed Articles

Year Published

Show more Refine

Article Type

Show more Refine

Article Statistics

Refine

MESH Headings

Show more Refine

First Author

Show more Refine

First Author Affiliations

Show more Refine

Authors

Show more Refine

Publication Titles

Show more Refine

Grant Agencies

Show more Refine

Countries/Regions

Show more Refine

Affiliations

Show more Refine

Corresponding Author Affiliations

Show more Refine

Category

Show more Refine

Number	Citation Analysis
1	Ulas EB, Bahce I. Neoadjuvant immunochemotherapy in resectable non-small cell lung cancer: the more cycles, the better? Transl Lung Cancer Res 2023;12:1369-1371. [PMID: 37577324 PMCID: PMC10413032 DOI: 10.21037/tlcr-23-329] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/20/2023] [Accepted: 07/05/2023] [Indexed: 08/15/2023] Abstract Collapse Key Words Non-small cell lung cancer (NSCLC) neoadjuvant immunochemotherapy treatment course length Collapse MESH Headings Collapse Grants Collapse Affiliation(s) Collapse

Number

Citation Analysis

Ulas EB, Bahce I. Neoadjuvant immunochemotherapy in resectable non-small cell lung cancer: the more cycles, the better? Transl Lung Cancer Res 2023;12:1369-1371. [PMID: 37577324 PMCID: PMC10413032 DOI: 10.21037/tlcr-23-329] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/20/2023] [Accepted: 07/05/2023] [Indexed: 08/15/2023]